Two Sigma Advisers »

Werewolf Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Werewolf Therapeutics (HOWL) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Werewolf Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Werewolf Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Werewolf Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $684k 177k 3.86

More positions owned by Two Sigma Advisers

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Merck & Co (MRK)
Micron Technology (MU)
Netflix (NFLX)
Paypal Holdings (PYPL)
Bristol Myers Squibb (BMY)
Qualcomm (QCOM)
Pinterest Cl A (PINS)
Meta Platforms Cl A (META)
General Motors Company (GM)

View all positions for Two Sigma Advisers

Top funds holding Werewolf Therapeutics

RA Capital Management
Partner Fund Management
Bank of America Corporation
Vanguard Group
Sphera Funds Management
Millennium Management
Alyeska Investment Group
Two Sigma Advisers
Two Sigma Investments
Laurion Capital Management
Dimensional Fund Advisors
Denali Advisors
HBK Sorce Advisory
Citadel Advisors
Raymond James Financial Services Advisors

View all funds holding Werewolf Therapeutics